Mon, Nov 3, 2025 ยท 10:00 AM
INSURANCE & COMMERCE- HOUSE
No transcript yet. This meeting is queued; the recap appears here once a transcript is on file.
ISP-2025-016
AN ACT TO MANDATE THE USE OF BIOSIMILAR MEDICINES UNDER HEALTH BENEFIT PLANS; TO REQUIRE A HEALTHCARE PROVIDER TO PRESCRIBE BIOSIMILAR MEDICINES; TO IMPROVE ACCESS TO BIOSIMILAR MEDICINES; AND FOR OTHER PURPOSES.
- Type
- Interim Study Proposal
- Status
- Adopted · Nov 3, 2025
- Committee
- INSURANCE & COMMERCE - SENATE
- Sponsors
- Justin Boyd, J. Boyd By: Achor
- Came from
- SB140 (To mandate the use of biosimilar medicines under health benefit plans; to require a...)
- ISP-2025-016 filing (PDF)
- Agenda · INSURANCE & COMMERCE- HOUSE · Nov 3, 2025
- EXHIBIT C - Minutes 12-16-2024 · Nov 3, 2025
- EXHIBIT D3 - ISP-2025-016 · Nov 3, 2025
- EXHIBIT E - Bekaert Fair and Efficient Transmission Compact Arkansas · Nov 3, 2025
- EXHIBIT F - DHS Act 615 · Nov 3, 2025
- HANDOUT 1 - SPP+101+smaller_ecs · Nov 3, 2025
| Date | Action |
|---|---|
| Nov 3, 2025 | Adopted |
Experimental. Compiled from public records; inaccuracies may occur. Verify with official sources.